Phase II Study for the Treatment of Poor Ovarian Responders With Corifollitropin Alfa Followed by hpHMG in a Short GnRH Agonist Protocol
Phase of Trial: Phase II
Latest Information Update: 09 May 2019
At a glance
- Drugs Corifollitropin alfa (Primary) ; Menotropin (Primary) ; Triptorelin (Primary)
- Indications Female infertility
- Focus Therapeutic Use
- 01 May 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 Mar 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 16 Jan 2013 Planned End Date changed from 1 Jan 2013 to 1 Mar 2013 as reported by ClinicalTrials.gov.